Brawn Biotech Ltd

Brawn Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Brawn Biotech Ltd

₹ 21.0 0.00%
04 Jun - close price
brawnbiotech.com BSE: 530207
About

Incorporated in 1985, Brawn Biotech Ltd is in the business of trading pharmaceutical products[1]

Key Points

Business Overview:[1]
BBL is a fully integrated healthcare company that deals in pharmaceutical products, covering segments:
a) Antibacterial
b) Cardiovascular
c) Antidiabetics
d) Analgesics
e) Gastrointestinal
f) Antifungals
g) Skin Care
h) Antipsychotics,
i) Anti-asthmatics
j) Antacids
k) Antimalarial
l) Nutritional

Website BSE
  • Market Cap ₹ 6.32 Cr.
  • Current Price ₹ 21.0
  • High / Low ₹ 24.4 / 16.2
  • Stock P/E 6.72
  • Book Value ₹ 14.5
  • Dividend Yield 0.00 %
  • ROCE 0.00 %
  • ROE 24.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company's working capital requirements have reduced from 130 days to 35.9 days

Cons

  • Promoter holding has decreased over last quarter: -0.45%
  • The company has delivered a poor sales growth of -13.5% over past five years.
  • Company has a low return on equity of -14.8% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
4.75 7.29 2.92 2.84 3.45 4.06 3.30 3.84 2.26 5.80 4.89 4.31 1.98
4.88 7.45 3.31 3.42 3.84 4.56 3.62 4.24 2.81 5.62 4.88 4.32 2.49
Operating Profit -0.13 -0.16 -0.39 -0.58 -0.39 -0.50 -0.32 -0.40 -0.55 0.18 0.01 -0.01 -0.51
OPM % -2.74% -2.19% -13.36% -20.42% -11.30% -12.32% -9.70% -10.42% -24.34% 3.10% 0.20% -0.23% -25.76%
0.00 0.00 0.00 0.00 0.08 0.00 0.00 0.00 0.09 0.09 0.09 0.09 0.18
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.04 0.02 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03
Profit before tax -0.17 -0.18 -0.42 -0.61 -0.34 -0.53 -0.35 -0.43 -0.49 0.24 0.07 0.05 -0.36
Tax % 258.82% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -261.11%
-0.61 -0.17 -0.42 -0.61 -0.34 -0.53 -0.34 -0.43 -0.49 0.24 0.07 0.05 0.58
EPS in Rs -2.03 -0.57 -1.40 -2.03 -1.13 -1.77 -1.13 -1.43 -1.63 0.80 0.23 0.17 1.93
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
38.65 46.88 59.78 55.71 65.18 49.62 34.98 8.53 22.23 16.49 13.46 16.98
38.09 45.44 58.53 53.75 64.01 48.89 35.58 10.53 22.53 17.95 15.23 17.31
Operating Profit 0.56 1.44 1.25 1.96 1.17 0.73 -0.60 -2.00 -0.30 -1.46 -1.77 -0.33
OPM % 1.45% 3.07% 2.09% 3.52% 1.80% 1.47% -1.72% -23.45% -1.35% -8.85% -13.15% -1.94%
0.04 0.01 0.61 0.09 0.74 0.17 0.31 0.00 0.01 0.08 0.09 0.45
Interest 0.10 0.11 0.07 0.06 0.07 0.05 0.04 0.06 0.01 0.06 0.00 0.00
Depreciation 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.05 0.11 0.10 0.11 0.12
Profit before tax 0.47 1.31 1.76 1.96 1.81 0.82 -0.36 -2.11 -0.41 -1.54 -1.79 0.00
Tax % 40.43% 27.48% 20.45% 34.69% 26.52% 28.05% 55.56% -22.27% 109.76% -19.48% -3.35%
0.28 0.95 1.39 1.28 1.33 0.59 -0.55 -1.64 -0.87 -1.25 -1.74 0.94
EPS in Rs 0.93 3.17 4.63 4.27 4.43 1.97 -1.83 -5.47 -2.90 -4.17 -5.80 3.13
Dividend Payout % 0.00% 31.58% 32.37% 23.44% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -10%
5 Years: -13%
3 Years: -9%
TTM: 26%
Compounded Profit Growth
10 Years: 0%
5 Years: 30%
3 Years: 46%
TTM: 154%
Stock Price CAGR
10 Years: -5%
5 Years: -8%
3 Years: 9%
1 Year: 28%
Return on Equity
10 Years: -1%
5 Years: -16%
3 Years: -15%
Last Year: 24%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00
Reserves 1.94 2.53 3.92 4.63 5.66 6.26 5.79 4.22 3.31 2.06 0.36 1.34
0.11 0.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
8.95 8.30 10.11 14.94 13.85 11.03 5.08 6.56 8.22 9.53 17.13 16.52
Total Liabilities 14.00 13.95 17.03 22.57 22.51 20.29 13.87 13.78 14.53 14.59 20.49 20.86
0.19 0.24 0.25 0.22 0.19 0.18 0.14 0.39 0.37 0.33 0.46 0.36
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.03 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
13.78 13.68 16.78 22.35 22.32 20.11 13.73 13.39 14.16 14.26 20.03 20.50
Total Assets 14.00 13.95 17.03 22.57 22.51 20.29 13.87 13.78 14.53 14.59 20.49 20.86

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0.23 0.05 1.37 -1.54 0.21 -0.08 0.03 0.19 0.32 -0.03 0.05 0.11
-0.12 -0.08 0.57 0.00 0.00 -0.02 0.00 -0.30 -0.10 -0.01 -0.24 -0.03
0.00 -0.05 -0.11 -0.06 -0.06 -0.05 -0.04 -0.06 -0.01 0.00 0.00 0.00
Net Cash Flow 0.11 -0.08 1.83 -1.60 0.15 -0.14 0.00 -0.17 0.21 -0.04 -0.20 0.08
Free Cash Flow 0.11 -0.03 1.34 -1.54 0.21 -0.10 0.03 -0.11 0.22 -0.04 -0.19 0.08
CFO/OP 41% 28% 170% -14% 88% 21% -52% -10% -103% 2% -3% -33%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 87.07 71.63 79.50 98.60 92.17 110.34 96.83 120.24 87.35 85.88 92.47 76.31
Inventory Days 11.17 4.50 2.59 2.62 2.12 3.38 3.16 261.82 91.20 153.02 320.33 253.06
Days Payable 73.72 44.59 47.70 83.93 64.58 74.47 32.34 224.66 123.19 144.12 252.10 362.48
Cash Conversion Cycle 24.52 31.54 34.39 17.29 29.72 39.25 67.65 157.41 55.36 94.78 160.70 -33.11
Working Capital Days 15.87 18.92 28.21 43.37 42.06 58.04 77.53 241.76 80.62 137.90 216.40 35.90
ROCE % 11.91% 26.54% 29.28% 27.77% 23.08% 9.71% -3.55% -25.61% -5.91% -25.86% -42.52% 0.00%

Insights

In beta
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Permanent Employees
Count

Log in to view insights

Please log in to see hidden values.

Login
Trade Receivable Turnover Ratio
Times

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
53.72% 53.72% 53.72% 53.64% 53.64% 53.64% 53.64% 53.66% 53.66% 53.66% 53.39% 52.94%
0.59% 0.59% 0.59% 0.35% 0.35% 0.35% 0.35% 0.35% 0.35% 0.35% 0.35% 0.35%
45.69% 45.69% 45.69% 46.02% 46.02% 46.02% 46.02% 46.01% 46.00% 45.99% 46.27% 46.72%
No. of Shareholders 6,2466,1946,1394,1604,0904,1574,0604,0243,9753,9583,4443,303

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports